Study
REUTERS The use of Pfizer Inc (PFE.N) and German partner BioNTech SE's (22UAy.DE) widely used COVID-19...
REUTERS A third dose of Pfizer (PFE.N)'s COVID-19 vaccine has significantly improved protection from infection and serious illness among people aged 60 and older in Israel c...
REUTERS Trial data from AstraZeneca (AZN.L) on Friday raised the prospect of a new treatment to prevent COVID-19 beyond vaccines, giving hope in particular for people who respond poorly to ...
REUTERS A British public health study has found that protection from either of the two most commonly used COVID-19 vaccines against the now prevalent Delta variant of the coronavirus weakens within three months. It also found that those who get..
Young children may be more likely to transmit the virus that causes COVID-19 within households compared with older children, a new study has found. Specifically, children 3 or younger were more likely to spread the virus to household members compa..
REUTERS Risk of Bell's Palsy, a type of facial paralysis, is higher after the first dose of Sinovac Biotech Ltd's (SVA.O) COVID-19 vaccine CoronaVac, according to a study published ...
REUTERS A two-dose COVID-19 vaccine from China's Sinopharm was 50.4% effective in preventing infections in health workers in Peru when it was seeing a surge in cases fuelled by virus variants, and booster shots can be considered, a study found..
REUTERS Moderna Inc (MRNA.O) is planning to double the size of an ongoing trial testing its COVID-19 vaccines in children aged six months to less than 12 years. According to upda...
REUTERS Antibody levels are a good predictor for how effective Moderna Inc's (MRNA.O) COVID-19 vaccine is, according to a new study released on Tuesday, a finding which could help spee...
Qatar Secures Place Among the World's Top 10 Wealthiest Nations
Hamad International Airport Witnesses Record Increase in Passenger Traffic
Saudi Arabia: Any visa holder can now perform Umrah
What are Qatar's Labour Laws on Annual Leave?